- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.01. | UK drug repurposing study identifies several potential dementia treatments | ||
| 24.01. | Creating and sustaining university biotech spin-outs | ||
| 23.01. | WHO urges US to 'reconsider' withdrawal from global health organisation | ||
| 23.01. | Takeda and EU Innovative Health Initiative launch Crohn's disease prevention study | ||
| 23.01. | LEO pharma gains EU rights to Junshi Biosciences' PD-1 inhibitor toripalimab | ||
| 23.01. | Unlocking innovation: how generative AI and data are reshaping healthcare marketing | ||
| 22.01. | AstraZeneca receives NICE recommendations for lung cancer drugs Tagrisso and Imfinzi | ||
| 22.01. | Sanofi's Sarclisa granted EC approval to treat newly diagnosed multiple myeloma | ||
| 22.01. | Chiesi report highlights incorrect inhaler use among UK asthma patients | ||
| 22.01. | The power of purpose | ||
| 21.01. | WHO launches $1.5bn emergency appeal to tackle ongoing health crises | ||
| 21.01. | Novo shares promising results for high-dose semaglutide in late-stage obesity study | ||
| 21.01. | Valneva shares positive phase 3 results for chikungunya vaccine in adolescents | ||
| 20.01. | AstraZeneca/Daiichi Sankyo's Datroway granted FDA approval in breast cancer | ||
| 20.01. | GSK's Jemperli combination approved by EC for expanded endometrial cancer use | ||
| 20.01. | Gilead's Livdelzi approved by MHRA to treat primary biliary cholangitis in adults | ||
| 17.01. | AstraZeneca's Calquence granted FDA approval in untreated mantle cell lymphoma | ||
| 17.01. | Amgen's Lumakras/Vectibix approved by FDA to treat metastatic colorectal cancer | ||
| 17.01. | ICR researchers uncover genes responsible for tumour progression in prostate cancer | ||
| 17.01. | PM Society Awards 2025 - tickets now on sale | ||
| 16.01. | Eli Lilly's Omvoh granted FDA approval to treat Crohn's disease in adults | ||
| 16.01. | Novo Nordisk and Valo Health expand alliance for cardiometabolic diseases | ||
| 16.01. | Santhera's Duchenne muscular dystrophy drug Agamree accepted by SMC | ||
| 15.01. | AbbVie and Simcere to advance multiple myeloma candidate in partnership worth over $1bn | ||
| 15.01. | Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer's drug |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
